BridgeBio Pharma, Inc(NASDAQ:BBIO) 
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs inc...
Website: http://www.bridgebio.com
Founded: 2015
IPO Price: $17 (Jun 27, 2019)
Full Time Employees: 369
CEO: Neil Kumar
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 33.37
H 33.88
L 30.86
C 31.37
V 4,015,230
10EMA 31.37
20EMA 31.37
60EMA 31.37
120EMA 31.37
250EMA 31.37